The biochemistry of alternative medicine: Curcumin: Old spice is a new medicine

Alternative and Complementary Therapies

Volumn 9, Issue 1, 2003, Pages 34-38

  Cronin, Joseph R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; CATECHIN; CURCUMIN; GINSENG EXTRACT; GREEN TEA EXTRACT; PIPERINE; TACRINE; UBIDECARENONE; VINBLASTINE; WARFARIN;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BLEEDING; BREAST CANCER; CLINICAL TRIAL; COLORECTAL CANCER; CURCUMA LONGA; DIABETIC RETINOPATHY; DRUG ISOLATION; HERB; HUMAN; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; PROSTATE CANCER; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0037315206     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/10762800360520776     Document Type: Review

References (48)

1. Hu Y, et al. Determination of chemical constituents of the volatile oil from Curcuma longa by gas chromatography-mass spectrometry. Hu Se Pu 1998;16:528-529.
2. Azuine MA, et al. Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo αpyrene-induced genotoxicity and carcinogenicity. J Cancer Res Clin Oncol 1992;118:447-452.
3. Yu ZF, et al. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol 2002;83:161-165.
4. Madan B, et al. Curcuma longa activates NF-kappaB and promotes adhesion of neutrophils to human umbilical vein endothelial cells. J Ethnopharmacol 2001;75:25-32.
5. 2-induced renal epithelial (LLC-PK1) cell injury. Free Radic Biol Med 1998;24:49-54.
6. Srinivas L, et al. Turmerin: A water soluble antioxidant peptide from turmeric (Curcuma longa). Arch Biochem Biophys 1992;292:617-623.
7. Online document at: www.ars-grin.gov/cgi-bin/duke/farmacy2.p l?331
8. Online document at: www.ars-grin.gov/cgi-bin/duke/chemical.pl?CURCUMIN
9. Online document at: www.ncbi.nim.nih.gov:80/entrez/query.fcgi?CMD=search&DB=PubMed
10. Online document at: www.curcuminoids.com/page7.htm
11. Marínela P M, et al. Histochemical evaluation of the rhizome of Curcuma longa cultivated in Venezuela. Trop Agronomy 1999;49:349-359.
12. Garg SN, et al. Variation in the rhizome essential oil and curcumin contents and oil quality in the land races of turmeric Curcuma longa of North Indian plains. Flavour Fragrance J 1999;14:315-318.
13. Kositchaiwat C. et al. Curcuma longa Linn. in the treatment of gastric ulcer: Comparison to liquid antacid. A controlled clinical trial. J Med Assoc Thai 1993;76:601-605.
14. Thamlikitkul V, et al. Randomized double blind study of Curcuma domestica Val. for dyspepsia. J Med Assoc Thai 1989;72:613-620.
15. Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992;36:273-275.
16. Kuttan R, et al. Turmeric and curcumin as topical agents in cancer therapy. Tumori 73:29-31, 1987
17. Satoskar RR, et al. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 1986;124:651-654.
18. Prucksunand C., et al. Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn.) on healing of peptic ulcer. Southeast Asian J Trop Med Public Health 2001;32:208-215.
19. Kelloff GJ, et al. Clinical development plan: Curcumin. J Cell Biochem 1996;26(suppl.):72-85.
20. Cheng AL, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-2900.
21. Sharma RA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001;7:1894-1900.
22. Online document at: clinicaltrials.gov/ct/gui/show/NCT00027495;jsessionid=F4410C4893 F0C7DC3BF347AA300CF818?order=1
23. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med. 1971;285:1182-1186.
24. Li N, et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 2002;23:1307-1313.
25. Shao ZM, et al. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002;98:234-240.
26. Dorai T, et al. Therapeutic potential of curcumin in human prostate cancer: III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001;47:293-303.
27. Thaloor D, et al. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 1998;9:305-312.
28. Okamoto, T. et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin [abstr.] FASEB J 2002;16:1928-1930.
29. Arbiser JL, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998;4:376-383.
30. Shin EY, et al. c-Jun N-terminal kinase is involved in motility of endothelial cell. Exp Mol Med 2001;33:276-283.
31. Mohan R. et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 2000;275:10405-10412.
32. Anuchapreeda S. et al. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002;64:573-582.
33. Park EJ, et al. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol 2000;52:437-440.
34. Song EK, et al. Diarylheptanoids with free radical scavenging and hepatoprotective activity in vitro from Curcuma longa. Planta Med 2001;67:876-877.
35. Mortellini R, et al. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000;28:1303-1312.
36. 4-induced liver necrosis in mice by naturally occurring methylenedioxybenzenes. Toxicol Appl Pharmacol 1996;140:411-421.
37. Kanofsky JR. Singlet oxygen production by biological systems. Chem Biol Interact 1989;70:1-28.
38. Das KC, Das CK. Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher. Biochem Biophys Res Commun 2002;295:62-66.
39. Khar A, et al. Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: Role of reactive oxygen intermediates. Cell Stress Chaperones 2001;6:368-376.
40. Quiles JL, et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 2002;22:1225-1231.
41. Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem Toxicol 2002;40:1091-1097.
42. Heck AM, et al. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000;57:1221-1227.
43. Deshpande SS, et al. Subchronic oral toxicity of turmeric and ethanolic turmeric extract in female mice and rats. Toxicol Lett 1998;95:183-189.
44. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol 1978;43:86-92.
45. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicol 1980;16:259-265.
46. Shoba, G. et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353-356.
47. Azuine MA, Bhide SV. Adjuvant chemoprevention of experimental cancer: Catechin and dietary turmeric in forestomach and oral cancer models. J Ethnopharmacol 1994;44:211-217.
48. Online document at: www.urmc.rochester.edu/pr/news/news.cfm?ID=125